From a Scare to Awareness: Lindsay Willis’s Mission to Educate on Melanoma Risks
By Mara Klecker Lindsay Willis grew up hearing her mother’s warnings about skin damage and skin cancers and remembers hearing…
07/23/2024
From a Scare to Awareness: Lindsay Willis’s Mission to Educate on Melanoma Risks
By Mara Klecker Lindsay Willis grew up hearing her mother’s warnings about skin damage and skin cancers and remembers hearing…
|
07/18/2024
Everything Coming up Rosy is not a Health Tune
People with the chronic inflammatory skin condition rosacea shouldn’t skip out on check-ups. According to a new research study from…
|
07/10/2024
Ways to Give: How You Can Donate Your Birthday Through Facebook
We often receive inquiries about how our community can support AIM at Melanoma. One of the simplest methods is to…
|
07/10/2024
Beyond the Clinic Podcast: Navigating the Storm: Managing Stress and Anxiety Through Your Cancer Journey
In this deeply insightful episode of our podcast, we explore the often-hidden challenges melanoma patients and survivors face—stress and anxiety.…
|
07/02/2024
Summary of Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
By Mandi Murph Treatment may be changing for patients with Stage III melanoma. Recent clinical trial results show improved outcomes…
|
07/02/2024
In Plain English: Overview of the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO)
By Kim Margolin, M.D., FACP, FASCO The American Society of Clinical Oncology or ASCO is a professional organization that…
|
|
06/15/2024
Stories of Strength: Three Melanoma Survivors Who Inspire Us All
June marks National Cancer Survivor Month, a time to honor the remarkable resilience and strength of those who have battled…
|
06/13/2024
World Health Organization Predicts Half a Million With Melanoma in 2040
Without intervention today, the number of people affected by melanoma will skyrocket. The World Health Organization warns that new diagnoses…
06/10/2024
Beyond the Clinic Podcast: Having Difficult Conversations
In this episode, we unlock one of the most challenging aspects of the cancer journey — having difficult conversations. Whether…
|
06/06/2024
Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma
Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in…
|
|
Recent Posts
Jul. 23, 2024
From a Scare to Awareness: Lindsay Willis’s Mission to Educate on Melanoma Risks
Jul. 18, 2024
Everything Coming up Rosy is not a Health Tune
Jul. 10, 2024
Ways to Give: How You Can Donate Your Birthday Through Facebook
Jul. 10, 2024
Beyond the Clinic Podcast: Navigating the Storm: Managing Stress and Anxiety Through Your Cancer Journey
Jul. 02, 2024